Cohance Lifesciences Ltd

₹456.75▲ +0.63%29 Sept

📊 Stock Analysis

Market Data

Market Cap₹17,473.75 Cr.

52W High₹917.5

Current Price₹456.75

52W Low₹267.85

Down from 52W High50.2 %

Face Value₹1

Performance

ROCE3.31 %

ROE2.72 %

EPS (TTM)₹-0.63

EPS Prev Qtr₹0.51

EPS Last Year₹1.94

EBITDA Qtr₹-48.38 Cr.

Book Value₹102

Financial Health

Debt/Equity0.04

Debt/Profit2.9

Total Assets₹5,729.64 Cr.

Promoter Holding57.49 %

Earning Power2.17 %

Valuation

Stock P/E298.53

Industry P/E33.3

Price to Book4.47

Price to Sales8.16

Graham Number₹59.31

Key Metrics

Face Value

₹1

About Cohance Lifesciences Ltd

Healthcare · Pharmaceuticals

Cohance Lifesciences Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹1. Market cap ₹17,473.75 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.9	₹4,46,276.3 Cr	0.86%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	85.97	₹2,51,531.48 Cr	0.32%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	78.4	₹1,86,956.51 Cr	0.77%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	26.64	₹1,19,221.66 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.13	₹1,11,725.01 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	98.01	₹1,07,271.96 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Mankind Pharma Ltd	-	51.42	₹1,05,107.48 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Dr Reddys Laboratories Ltd	-	32.31	₹1,04,334.48 Cr	0.64%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Aurobindo Pharma Ltd	-	26.61	₹97,986.86 Cr	0.23%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.63	₹94,189.9 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	37.59	₹67,587.09 Cr	0.1%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	29.02	₹62,609.02 Cr	1.01%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	111.18	₹61,602.44 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.88	₹57,939.73 Cr	1.74%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Gland Pharma Ltd	-	43.62	₹49,299.85 Cr	0.67%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ipca Laboratories Ltd	-	36.55	₹49,280.78 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	85	₹49,084.9 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Glaxosmithkline Pharmaceuticals Ltd	-	44.95	₹47,217.7 Cr	2.05%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ajanta Pharma Ltd	-	39.17	₹44,452.1 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	555.57	544.55	619.12	422.26
↳ QoQ Growth	-	-2.0%	+13.7%	-31.8%
Expenses	478.64	496.14	571.67	470.64
Operating Profit	76.93	48.41	47.45	-48.38
OPM %	13.85%	8.89%	7.66%	-11.46%
Other Income	15.6	6.16	-1.84	12.25
Interest	8.76	9.11	9.19	6.74
Depreciation	44.02	46.94	51.23	49.54
EBITDA	120.95	95.35	98.68	1.16
EBITDA Margin %	21.77%	17.51%	15.94%	0.27%
Profit Before Tax	83.77	40.6	19.91	-42.87
Tax %	20.75%	28.52%	58.26%	-5.41%
Net Profit	66.39	29.02	8.31	-45.19
↳ QoQ Growth	-	-56.3%	-71.4%	-643.8%
EPS	1.94	0.96	0.51	-0.63

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	25.46	38.26
Reserves	3623.36	3873.03
Borrowings	485.93	169.67
Other Liabilities	1346.21	1648.68
Total Liabilities	5480.96	5729.64
Fixed Assets	1764.8	3373.25
CWIP	331.6	173.22
Investments	337.16	528.55
Other Assets	3047.4	1654.62
Total Assets	5480.96	5729.64

Cash Flows

	Mar 2025	Mar 2026
Cash from Operating Activity	288.16	368.32
Cash from Investing Activity	-255.3	-254.57
Cash from Financing Activity	3.32	-165.15
Net Cash Flow	36.18	-51.4

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	57.49%	57.49%	57.49%	57.49%
FIIs %	6.51%	6.02%	5.59%	6.5%
DIIs %	20.82%	21.56%	21.79%	20.09%
Public %	6.42%	6.76%	7.04%	7.71%
No. of Shareholders	75,284	81,877	85,230	99,149